Your Subtitle text

Alzheimer's Drugs 

Alzheimer's News

Alzheimer's Disease News
May 11, 2012 11:59PM

http://www.dailyrx.com/taxonomy/term/743/all/feed

May 09, 2012 10:14AM

Slowing Brain Activity

Mild cognitive impairment (MCI) is a loss of thinking skills that increases risk of Alzheimer’s Disease. Areas of the brain are overactive in MCI, and new research shows that lowering the activity may improve memory.

Higher levels of brain activity in the hippocampus, a brain region important for memory, are common in MCI. Using a drug to lower that brain activity led to better memory function for patients with MCI.

read more

May 08, 2012 10:32AM

Avoiding Alzheimer?s With Purpose

Purpose in life can be as simple as having a hobby or connecting with family. New research points to having purpose in life to keep memory and thinking going strong.

read more

May 06, 2012 09:56PM

Alzheimer?s Drug Does not Relieve Agitation

A new study shows that Namenda (memantine), used in the treatment of Alzheimer’s Disease (AD), does not improve agitation symptoms.

As AD progresses, agitation is a common symptom that often appears as restlessness, anxiousness, or becoming easily upset.

A recent study looked at this aspect, specifically, and found that Namenda did not appear to offer any benefit to these symptoms.

read more

May 03, 2012 09:26AM

Onset Age of Alzheimer?s may Predict Symptoms

Alzheimer’s disease is typically divided into two categories: early onset and late onset. New research shows that the specific types of deficits experienced may be related to the type or onset age of the disorder.

read more

May 02, 2012 02:44PM

Nuts May Help Your Noggin

Have an extra slice of salmon each week, or add some almonds to your weekly snacks - it may help keep your mind clearer for longer as you get on in years.

A recent study has found a link between eating foods with omega-3 fatty acids and lower levels of a protein that's related to Alzheimer's disease. Foods like fish, nuts and chicken are sources of omega-3s.

read more

Apr 21, 2012 05:10AM

Dementia to Triple by 2050

The number of people with dementia is estimated at 35.6 million.  By 2030, the number of people with dementia is expected to double. By 2050, the number may triple.

read more

Apr 18, 2012 02:06PM

Every Bit of Physical Activity Helps

Vigorous exercise isn't the only physical activity that improves your health. Even activities like playing cards or sweeping can offer protective benefits well into your twilight years.

read more

Apr 17, 2012 06:42AM

Soul Man's Soul Rests in Peace

Sweet Caroline. Dock of the Bay. Soul Man. Suspicious Minds. Angel of Harlem. Let's Stay Together. Mustang Sally. You know the singers, but do you know who played those soulful horns?

read more

Apr 16, 2012 07:27AM

The Basics of Alzheimer?s Disease

According to the National Institute on Aging, an estimated 5.1 million Americans suffer from Alzheimer’s Disease.  Symptoms typically develop in people over 60 and can interfere with daily life dramatically as the disease progresses.

read more

Apr 15, 2012 02:48PM

Is it Really Alzheimer?s?

Correct diagnosis is key to the proper treatment of any disease. Alzheimer’s disease is responsible for 60%-80% of dementia cases, yet it is often misdiagnosed. New testing drugs are being created to increase diagnostic accuracy.

read more

Video Overview: Alzheimer's

What is Alzheimer's Disease?

Alzheimer's disease is the most common form of dementia in the United States affecting approximately 5.3 million people, and the number is growing. Alzheimer’s results in memory loss, decline in cognitive functioning, and behavioral changes.

Alzheimer's disease is usually diagnosed clinically from the patient history, statements from relatives, and clinical observations. There is no cure, and treatment efforts are aimed at slowing the progression of the disease and treating its symptoms.

Prescription medications such as Namenda (NMDA receptor antagonist) and Aricept (cholinesterase inhibitor) have been shown to slow progression by altering the amounts of certain neurotransmitters in the brain to improve neuronal communication.
Reviewed by:
Review Date:
Joseph V. Madia, MD
Friday, June 17, 2011

Source: FDA